123 related articles for article (PubMed ID: 34178583)
1. Nephrectomy Delay of More than 10 Weeks from Diagnosis Is Associated with Decreased Overall Survival in pT3 RCC.
Zeng J; Batai K; Lee BR
J Kidney Cancer VHL; 2021; 8(2):27-33. PubMed ID: 34178583
[TBL] [Abstract][Full Text] [Related]
2. The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm.
Mano R; Vertosick EA; Hakimi AA; Sternberg IA; Sjoberg DD; Bernstein M; Dalbagni G; Coleman JA; Russo P
Urol Oncol; 2016 May; 34(5):239.e1-8. PubMed ID: 26795607
[TBL] [Abstract][Full Text] [Related]
3. Racial and Ethnic Disparities in Preoperative Surgical Wait Time and Renal Cell Carcinoma Tumor Characteristics.
Quinonez-Zanabria E; Valencia CI; Asif W; Zeng J; Wong AC; Cruz A; Chipollini J; Lee BR; Gachupin FC; Hsu CH; Batai K
Healthcare (Basel); 2021 Sep; 9(9):. PubMed ID: 34574957
[TBL] [Abstract][Full Text] [Related]
4. Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease-A National Register Study.
Almdalal T; Sundqvist P; Harmenberg U; Hellström M; Lindskog M; Lindblad P; Lundstam S; Ljungberg B
Eur Urol Open Sci; 2022 May; 39():22-28. PubMed ID: 35528783
[TBL] [Abstract][Full Text] [Related]
5. Impact of surgical waiting time on survival in patients with upper tract urothelial carcinoma: A national cancer database study.
Xia L; Taylor BL; Pulido JE; Guzzo TJ
Urol Oncol; 2018 Jan; 36(1):10.e15-10.e22. PubMed ID: 29031419
[TBL] [Abstract][Full Text] [Related]
6. Impact of Time-To-Surgery on the Prognosis of Patients with T1 Renal Cell Carcinoma: Implications for the COVID-19 Pandemic.
Ou W; Wang C; Un H; Guo S; Xiao H; Huang B; Li B; Lei J; Wei J; Peng S; Luo J; Wang Z; Chen L
J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556133
[TBL] [Abstract][Full Text] [Related]
7. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
8. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.
Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B
Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Cryoablation for Stage 1 Renal Cell Carcinoma: Outcomes from a 10-year Prospective Study and Comparison with Matched Cohorts from the National Cancer Database.
Morkos J; Porosnicu Rodriguez KA; Zhou A; Kolarich AR; Frangakis C; Rodriguez R; Georgiades CS
Radiology; 2020 Aug; 296(2):452-459. PubMed ID: 32515677
[TBL] [Abstract][Full Text] [Related]
10. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
11. Assessing the role of race in pathological upstaging of renal cell carcinoma: Results from the National Cancer Database.
Suss NR; Bruha MJ; Monaghan TF; Robins D; Flores V; Agudelo CW; Smith M; Hyacinthe L; McNeil BK; Weiss J; Winer A
Int J Clin Pract; 2021 Apr; 75(4):e13818. PubMed ID: 33159366
[TBL] [Abstract][Full Text] [Related]
12. A Multi-Institutional Analysis of the Effect of Positive Surgical Margins Following Robot-Assisted Partial Nephrectomy on Oncologic Outcomes.
Rothberg MB; Paulucci DJ; Okhawere KE; Reynolds CR; Badani KK; Abaza R; Eun D; Bhandari A; Porter J; Hemal AK
J Endourol; 2020 Mar; 34(3):304-311. PubMed ID: 31931607
[No Abstract] [Full Text] [Related]
13. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
14. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
16. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
17. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
18. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice.
Wang DC; Plante K; Stewart T; Wang D; Formica M; Daugherty M; Bratslavsky G
Urol Oncol; 2017 Nov; 35(11):660.e9-660.e15. PubMed ID: 28736248
[TBL] [Abstract][Full Text] [Related]
19. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and prognostic implications for pathologic upstaging to T3a after partial nephrectomy.
Beksac AT; Paulucci DJ; Gul Z; Reddy BN; Kannappan M; Martini A; Sfakianos JP; Gin GE; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter J; Badani KK
Minerva Urol Nefrol; 2019 Aug; 71(4):395-405. PubMed ID: 30230296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
